Literature DB >> 8605174

In vitro selection analysis of neomycin binding RNAs with a mutagenized pool of variants of the 16S rRNA decoding region.

M Famulok1, A Hüttenhofer.   

Abstract

An in vitro selection for neomycin B binding was carried out with an RNA pool containing a 47-nucleotide domain of the decoding region of 16S ribosomal RNA, mutated at 30% per base position. The degenerate region was comprised of an oligonucleotide analogue ("motif A") of the decoding region in 30S subunits which has previously been shown to interact with the aminoglycoside antibiotic neomycin B and tRNA ligands. After five cycles of selection/amplification, RNA sequences were isolated which specifically bound to neomycin B. Cloning and sequencing showed that none of the isolated clones shared primary sequence or secondary structure homology with the decoding region of 16S RNA. Instead, a new set of sequences was isolated which could be folded into a defined hairpin structure designated as motif B. We investigated the affinity of motif A, motif B, the unselected pool RNA, and the corresponding unmutagenized "parent" RNA to neomycin B at different Mg2+ concentrations. Under buffer conditions of low ionic strength all RNAs tested bound nonspecifically to neomycin B. However, motif B bound to neomycin B at Mg2+ concentrations at which binding of the other RNAs tested was significantly lower or not detectable. This is consistent with motif B exhibiting a higher affinity for neomycin B than motif A under these conditions. Motif B has previously been isolated from an in vitro selection to identify RNA sequences with affinity to neomycin B using a completely randomized RNA pool which shared no relationship to motif A. Our results indicate that motif B might represent a highly optimized RNA sequence for neomycin B binding; conversely, the A-site motif in 16S rRNA (motif A) might not be an optimal target for neomycin B recognition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605174     DOI: 10.1021/bi952479r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  RNA aptamers specifically interact with the prion protein PrP.

Authors:  S Weiss; D Proske; M Neumann; M H Groschup; H A Kretzschmar; M Famulok; E L Winnacker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Screening for engineered neomycin riboswitches that control translation initiation.

Authors:  Julia E Weigand; Martin Sanchez; Ewald-Bernd Gunnesch; Sabrina Zeiher; Renee Schroeder; Beatrix Suess
Journal:  RNA       Date:  2007-11-13       Impact factor: 4.942

3.  An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA.

Authors:  H Miyaguchi; H Narita; K Sakamoto; S Yokoyama
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

4.  Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions.

Authors:  J A Cowan; T Ohyama; D Wang; K Natarajan
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

5.  Riboswitch control of induction of aminoglycoside resistance acetyl and adenyl-transferases.

Authors:  Weizhi He; Xuhui Zhang; Jun Zhang; Xu Jia; Jing Zhang; Wenxia Sun; Hengyi Jiang; Dongrong Chen; Alastair I H Murchie
Journal:  RNA Biol       Date:  2013-07-15       Impact factor: 4.652

6.  In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics.

Authors:  S T Wallace; R Schroeder
Journal:  RNA       Date:  1998-01       Impact factor: 4.942

7.  Recent trends in SELEX technique and its application to food safety monitoring.

Authors:  Jingjing Wu; Yingyue Zhu; Feng Xue; Zhanlong Mei; Li Yao; Xin Wang; Lei Zheng; Jian Liu; Guodong Liu; Chifang Peng; Wei Chen
Journal:  Mikrochim Acta       Date:  2014-04       Impact factor: 5.833

8.  RNASTAR: an RNA STructural Alignment Repository that provides insight into the evolution of natural and artificial RNAs.

Authors:  Jeremy Widmann; Jesse Stombaugh; Daniel McDonald; Jana Chocholousova; Paul Gardner; Matthew K Iyer; Zongzhi Liu; Catherine A Lozupone; John Quinn; Sandra Smit; Shandy Wikman; Jesse R R Zaneveld; Rob Knight
Journal:  RNA       Date:  2012-05-29       Impact factor: 4.942

9.  Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.

Authors:  Craig B Wilen; Jianbin Wang; John C Tilton; Jeffrey C Miller; Kenneth A Kim; Edward J Rebar; Scott A Sherrill-Mix; Sean C Patro; Anthony J Secreto; Andrea P O Jordan; Gary Lee; Joshua Kahn; Pyone P Aye; Bruce A Bunnell; Andrew A Lackner; James A Hoxie; Gwenn A Danet-Desnoyers; Frederic D Bushman; James L Riley; Philip D Gregory; Carl H June; Michael C Holmes; Robert W Doms
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

Review 10.  Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling.

Authors:  Andrea Conidi; Veronique van den Berghe; Danny Huylebroeck
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.